U.S. Irradiation Apparatus Market Summary

The U.S. irradiation apparatus market size was estimated at USD 2.88 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030. The rising demand for non-invasive medical procedures is one of the most significant drivers contributing to this growth. With both patients and healthcare providers increasingly preferring alternatives to traditional invasive methods, the adoption of irradiation apparatus has expanded. Non-invasive procedures often require precise sterilization, advanced imaging, and sophisticated medical equipment, thereby increasing reliance on irradiation devices. Additionally, their growing usage in nuclear medicine for both diagnostic and therapeutic applications further accelerates market expansion, offering improved accuracy and effectiveness in clinical practice.

The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, musculoskeletal conditions, prostate cancer, and breast cancer has strongly boosted the demand for non-invasive diagnostic solutions. These medical conditions necessitate advanced imaging technologies, where irradiation apparatus such as X-ray devices play a crucial role. Such systems enable early detection, precise diagnosis, and timely treatment interventions without the need for invasive procedures, ensuring better patient outcomes. For instance, in 2022, the total number of cancer cases in the U.S. reached 1.9 million. According to the American Cancer Society, lung cancer remains one of the most frequently diagnosed cancers, with over 234,580 new cases expected in 2024 alone. Additionally, prostate cancer also remains a major concern, with 230,125 cases reported in 2022. These rising statistics highlight the critical importance of irradiation apparatus in ensuring timely, effective, and non-invasive care, reinforcing the growing shift within the healthcare sector toward safer diagnostic and therapeutic options.

Key Market Trends & Insights

• Among product categories, the X-ray segment accounted for the largest market share of about 32.64% in 2024. This segment’s growth is largely fueled by the increasing demand for diagnostic imaging services across the U.S., driven by the rising burden of chronic diseases such as cancer and cardiovascular conditions. X-ray devices remain the most commonly used irradiation apparatus in clinical settings due to their efficiency, cost-effectiveness, and ability to detect a broad range of health issues at early stages. Continuous improvements in X-ray technologies, including enhanced image resolution and lower radiation doses, are expected to further drive adoption in the coming years.
• Based on applications, diagnostics dominated the market with the largest share of about 39.91% in 2024. The increasing demand for non-invasive diagnostic imaging solutions is driving continuous innovation within this segment. Advancements such as faster imaging times, integration of 3D imaging, and the development of dose-reduction technologies are enabling more precise and safer diagnostic outcomes. This strong emphasis on enhancing imaging accuracy and minimizing patient exposure has positioned diagnostic applications as a key growth driver for irradiation apparatus in the U.S. market.
• By end-use, the hospitals segment led the market with a share of about 43.7% in 2024. Hospitals are heavily investing in upgrading and expanding their medical imaging infrastructure to improve patient care, efficiency, and treatment outcomes. In addition to their reliance on diagnostic equipment, hospitals also utilize irradiation apparatus extensively for therapeutic applications such as radiotherapy, which remains an essential treatment modality for various cancers. This dual role of diagnostics and therapy has positioned hospitals as the largest end-users of irradiation apparatus, contributing significantly to the overall market growth.

Order a free sample PDF of the U.S. Irradiation Apparatus Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 2.88 billion
• 2030 Projected Market Size: USD 4.07 billion
• CAGR (2025 - 2030): 6.0%

Key Companies & Market Share Insights

Major U.S. irradiation apparatus industry players are actively enhancing their product offerings to capture a larger market share and expand their customer base. These companies are investing in the latest technological upgrades to improve the quality and efficiency of their irradiation apparatus. Moreover, they are pursuing strategic acquisitions to broaden their service portfolios and enter new geographic regions, strengthening their market position. In addition, partnerships with other healthcare providers and technology firms are being formed to leverage complementary strengths and integrate innovative solutions. Securing government clearances and regulatory approvals also remains critical for these organizations.

Key Players

• Siemens Healthineers (Varian Medical Systems, Inc.)
• Elekta
• GE HealthCare
• Accuray Incorporated
• IBA Radiopharma Solutions
• Koninklijke Philips N.V.
• Nordion (Canada) Inc.
• STERIS
• Precision X-Ray
• Carestream Dental LLC.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. irradiation apparatus market is experiencing steady growth, driven by increasing demand for non-invasive medical procedures, a rising burden of chronic diseases, and rapid advancements in imaging technologies. The dominance of X-ray devices and diagnostic applications highlights the crucial role of imaging in early detection and treatment planning, while hospitals remain the primary end-users due to their wide-ranging diagnostic and therapeutic needs. With cancer and cardiovascular diseases becoming more prevalent, the importance of advanced, accurate, and safe imaging solutions is expected to intensify. Overall, the market is positioned for sustainable growth as healthcare continues shifting toward patient-centric, non-invasive approaches.